Rocket


Overview
Financials
News + Filings
Key Docs
Ownership





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

RedHill Biopharma Ltd. (RDHL)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   20-F20-F20-F20-F20-F20-F20-F20-F
OPERATING ACTIVITIES:          
    Comprehensive loss          
    Adjustments in respect of income and expenses not involving cash flow:          
        Share-based compensation to employees and service providers          
        Depreciation          
        Amortization and impairment of intangible assets          
        Non-cash interest expenses related to borrowing and payable in respect of intangible assets purchase          
        Fair value adjustments on derivative financial instruments          
        Fair value (gains) losses on financial assets at fair value through profit or loss          
        Exchange differences and revaluation of bank deposits          
            Total adjustments in respect of income and expenses not involving cash flow          
Changes in assets and liability items:          
    Increase in trade receivables          
    Decrease (increase) in prepaid expenses and other receivables          
    Increase in inventories          
    Increase in accounts payable          
    Increase (decrease) in accrued expenses and other liabilities  -3.219.3-2.70.7  1.7 
    Increase in allowance for deductions from revenue  12.417.11.30.3    
    Total changes in assets and liability items          
        Net cash used in operating activities          
INVESTING ACTIVITIES:          
    Purchase of fixed assets          
    Purchase of intangible assets          
    Change in investment in current bank deposits  -8.510.2-2.14.9-13.036.8-29.5 
    Purchase of financial assets at fair value through profit or loss          
    Proceeds from sale of financial assets at fair value through profit or loss          
        Net cash provided by (used in) investing activities          
FINANCING ACTIVITIES:          
    Proceeds from long-term borrowing, net of transaction costs   78.1      
    Proceeds from issuance of ordinary shares, net of issuance costs          
    Exercise of options into ordinary shares  4.00.10.00.43.4   
    Repayment of payable in respect of intangible asset purchase  -7.4  -0.5    
    Increase in restricted cash   -20.0      
    Decrease in restricted cash   4.0      
    Payment of principal with respect to lease liabilities          
        Net cash provided by financing activities          
    INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS          
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS          
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD          
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF PERIOD          
SUPPLEMENTARY INFORMATION ON INTEREST RECEIVED IN CASH  0.00.40.80.70.50.40.2 
SUPPLEMENTARY INFORMATION ON INTEREST PAID IN CASH  11.36.70.3     
Acquisition of right-of-use assets by means of lease liabilities  0.32.92.8     
Purchase of intangible assets posted as payable   24.6      
Purchase of an intangible asset in consideration for issuance of shares   1.911.8     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy